Literature DB >> 22314607

Thrombin and cancer: from molecular basis to therapeutic implications.

Massimo Franchini1, Pier Mannuccio Mannucci.   

Abstract

The relationship between cancer and thrombosis has been recognized for nearly 150 years. Although the mechanisms underlying this association are not completely understood, there are increasing evidences suggesting a pivotal role of thrombin in cancer biology. This review will focus on the most important pathways by which thrombin may affect cancer growth and dissemination. In addition, the potential role of congenital (i.e., hemophilia) and pharmaceutical (i.e., antithrombotic agents) anticoagulation in cancer incidence and survival will be investigated through the analysis of the published experimental and clinical studies. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314607     DOI: 10.1055/s-0031-1300955

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  14 in total

Review 1.  Venous thrombosis and cancer: from mouse models to clinical trials.

Authors:  Y Hisada; J E Geddings; C Ay; N Mackman
Journal:  J Thromb Haemost       Date:  2015-06-26       Impact factor: 5.824

2.  High relative density of lymphatic vessels predicts poor survival in tongue squamous cell carcinoma.

Authors:  Miia Seppälä; Konsta Pohjola; Jussi Laranne; Markus Rautiainen; Heini Huhtala; Risto Renkonen; Karl Lemström; Timo Paavonen; Sanna Toppila-Salmi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-21       Impact factor: 2.503

Review 3.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

Review 4.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 5.  Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond.

Authors:  Sven Danckwardt; Matthias W Hentze; Andreas E Kulozik
Journal:  J Mol Med (Berl)       Date:  2013-08-17       Impact factor: 4.599

6.  Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer.

Authors:  Shruti Chaturvedi; Surbhi Sidana; Paul Elson; Alok A Khorana; Keith R McCrae
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

7.  Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.

Authors:  Elena Boggio; Chiara Dianzani; Casimiro Luca Gigliotti; Maria Felicia Soluri; Nausicaa Clemente; Giuseppe Cappellano; Erika Toth; Davide Raineri; Benedetta Ferrara; Cristoforo Comi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  J Immunol Res       Date:  2016-07-13       Impact factor: 4.818

8.  PAR-3 knockdown enhances adhesion rate of PANC-1 cells via increased expression of integrinαv and E-cadherin.

Authors:  Liora Segal; Liora S Katz; Hagit Shapira; Judith Sandbank; Elizabeth Geras-Raaka; Marvin C Gershengorn; Yoram Oron
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

Review 9.  The new oral anticoagulants and the future of haemostasis laboratory testing.

Authors:  Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

Review 10.  Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics.

Authors:  Domenica Musumeci; Chiara Platella; Claudia Riccardi; Federica Moccia; Daniela Montesarchio
Journal:  Cancers (Basel)       Date:  2017-12-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.